All Data Analysis articles
-
NewsMSD-Moderna Phase III readout backs personalised mRNA neoantigen combination adjuvant therapy for melanoma
First combination regimen to demonstrate significant reduction in recurrence risk in completely resected stage IIB-IV melanoma compared to Keytruda alone as adjuvant treatment.
-
ArticleLab 4.0 balance: connected, compliant and ready to integrate
Combining connectivity, compliance and automation, Lab 4.0 connectivity simplifies workflows, reduces manual intervention and supports secure digital transformation in modern pharmaceutical laboratories.
-
NewsAbCellera’s ABCL635 delivers positive Phase II data for vasomotor symptoms
In early Phase II data, investigational antibody ABCL635 achieved all primary efficacy endpoints in postmenopausal women experiencing vasomotor symptoms.
-
WebinarModernising pharma QA/QC laboratories: preparing for a more connected, compliant future
Join this webinar to discover how modern QA/QC laboratories are embracing digital transformation to enhance compliance, workflows and data integrity to build a more connected, future-ready pharmaceutical quality ecosystem.
-
WebinarEnsuring drug quality: mastering stability testing in pharma
Join this webinar to discover how UV-Vis spectroscopy and gas chromatography support API monitoring, testing and analysis.
-
ReportPharma Horizons: Nitrosamines
EPR’s 2026 nitrosamines report covers the key developments in manufacturing, quality, regulation, analytical development and beyond.
-
ReportPharma Horizons: Process Analytical Technology (PAT)
The definitive guide to transitioning from manual, offline batch testing to automated, continuous biomanufacturing.
-
ArticleSelecting the right qPCR workflow strategy: task-based vs. full automation
Selecting the right qPCR workflow strategy: task-based vs. full automation
-
ReportPharma Horizons: Cell and Gene Therapy
EPR’s 2026 cell and gene therapy report covers the key developments in manufacturing, regulation, drug delivery, process development and beyond.
-
NewsBoehringer’s GLP-1 dual agonist survodutide shines in phase III trial
Survodutide could become first global glucagon/GLP-1 dual agonist, new phase III findings suggest.
-
NewsManufacturing data innovation set to accelerate medicine development
CMAC’s milestone aids the pharmaceutical industry’s transition from manual and siloed data operations to connected, intelligent manufacturing systems.
-
NewsUpcycled plastic could facilitate production of Parkinson’s drug
Bioengineered E.coli provide an eco alternative to creating L-DOPA from terephthalic acid, suggests study.
-
NewsSana's islet cell transplant therapy shows early promise in type 1 diabetes
Biotech company’s long-term data demonstrated hypoimmune (HIP)-modified islet transplantation without immunosuppression in type 1 diabetes.
-
NewsStudy optimises automated de-bagging in aseptic manufacturing
Mechanical design improvements greatly enhanced success rate during primary de-bagging for double-bag products.
-
NewsFDA revises PK study approach in new biosimilar draft guidance
Sandoz is also adjusting its global strategy by recruiting Armin Metzger as President of Biosimilar Development, Manufacturing & Supply.
-
NewsCleanroom air quality not impaired by height-adjustable furniture
Incorporating ergonomic improvements into pharmaceutical cleanrooms may not negatively impact particle contamination control, according to a new study.
-
NewsNanofiltration study highlights next-generation water treatment process
The technology could offer defect-free, high-efficiency ceramic-based water filtration through ultra-precise control of nanopores and surface structure.
-
NewsBiogen/Stoke’s zorevunersen hailed as potential first disease-modifying drug for rare epilepsy
Clinical readout for Dravet syndrome trial part of the collaboration the companies signed in 2025.
-
NewsEnhanced fluorescence technique optimises bacterial detection
Study findings could improve fluorescence-based bacterial quantification.
-
NewsNovel rapid microbiological detection method could advance surface monitoring
Innovative approach provides a promising alternative to culture-based methods for routine microbial surface monitoring.